Business Description
Kronos Bio Inc
NAICS : 541714
SIC : 2833
ISIN : US50107A1043
Share Class Description:
KRON: Ordinary SharesDescription
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.84 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -0.32 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -5.34 | |||||
| Beneish M-Score | -2.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.1 | |||||
| 3-Year EPS without NRI Growth Rate | 28.9 | |||||
| 3-Year FCF Growth Rate | 22.2 | |||||
| 3-Year Book Growth Rate | -32.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.04 | |||||
| 9-Day RSI | 60.71 | |||||
| 14-Day RSI | 55.57 | |||||
| 6-1 Month Momentum % | 23.4 | |||||
| 12-1 Month Momentum % | -16.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.32 | |||||
| Quick Ratio | 8.32 | |||||
| Cash Ratio | 8.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 5.71 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -837.68 | |||||
| Net Margin % | -867.66 | |||||
| FCF Margin % | -787.33 | |||||
| ROE % | -60.36 | |||||
| ROA % | -45.11 | |||||
| ROIC % | -187.77 | |||||
| ROC (Joel Greenblatt) % | -334.05 | |||||
| ROCE % | -48.77 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.76 | |||||
| PB Ratio | 0.52 | |||||
| Price-to-Tangible-Book | 0.52 | |||||
| EV-to-EBIT | 0.51 | |||||
| EV-to-Forward-EBIT | -0.07 | |||||
| EV-to-EBITDA | 0.52 | |||||
| EV-to-Revenue | -4.23 | |||||
| EV-to-FCF | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 0.64 | |||||
| Price-to-Net-Cash | 0.67 | |||||
| Earnings Yield (Greenblatt) % | 196.08 | |||||
| FCF Yield % | -135.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KRON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kronos Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.864 | ||
| EPS (TTM) ($) | -1.43 | ||
| Beta | 2.23 | ||
| Volatility % | 77.14 | ||
| 14-Day RSI | 55.57 | ||
| 14-Day ATR ($) | 0.060612 | ||
| 20-Day SMA ($) | 0.897365 | ||
| 12-1 Month Momentum % | -16.86 | ||
| 52-Week Range ($) | 0.69 - 1.6 | ||
| Shares Outstanding (Mil) | 60.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kronos Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kronos Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kronos Bio Inc Frequently Asked Questions
What is Kronos Bio Inc(KRON)'s stock price today?
The current price of KRON is $0.95. The 52 week high of KRON is $1.60 and 52 week low is $0.69.
When is next earnings date of Kronos Bio Inc(KRON)?
The next earnings date of Kronos Bio Inc(KRON) is 2025-03-21 Est..
Does Kronos Bio Inc(KRON) pay dividends? If so, how much?
Kronos Bio Inc(KRON) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers